Oxford BioTherapeuticsis focused on the targeted treatment of cancer.
Company (Alive / Active)
86 Milton Park
|Investor||Investor Type||Location||Participating Rounds|
|Gaithersburg, Maryland, United States||IPO / Went public||GlycoMimetics is developing small molecule drugs that mimic the actions of carbohydrates using glycobiology. The company is focusing its initial efforts on therapeutics to treat inflammatory diseases such as cystic fibrosis and cancer.||Login to see details|
|Rockville, Maryland, United States||IPO / Went public||MacroGenics is a biotechnology company focused on the discovery, development, and delivery to patients of biologics for treatment of cancer, autoimmune disorders, and infectious diseases. MacroGenics has built a fully-integrated set of capabilities in antibody-based product development which supports its innovative pipeline of clinical stage product candidates. MacroGenics' research is based on three core technology platforms, which include, a leading research capability for screening and target...Show all||Login to see details|
|Title||Application Date||Patent Date||Status
(Patent / Application)